While the data looks promising, it is early to speculate on commercialization due to patients having side-effects such as breathing difficulties. There is a scope for further optimizing the treatment strategy which can take one step closure to commercialization.
While the data looks promising, it is early to speculate on...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.010(2.47%) |
Mkt cap ! $573.7M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.8¢ | 39.0¢ | $1.291M | 3.270M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 160217 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 119125 | 4 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |